Dr. Christopher Aaron Gilmore, MD

Dr. Gilmore practices at Carolinas Pain Institute, PA in Winston Salem, North Carolina.

Dr. Gilmore's NPI, 1225245707, was assigned on May 16, 2007. Dr. Gilmore graduated from University of Tennessee, Hsc, College of Medicine in 2002. Dr. Gilmore holds North Carolina license 2006-00944.

Dr. Gilmore's primary practice is Carolinas Pain Institute, PA, at 145 Kimel Park Dr, Winston Salem, NC 27103 in Forsyth County. The practice phone is (336) 765-6181.

Dr. Gilmore's primary practice is Carolinas Pain Institute, PA in Winston Salem, North Carolina. Dr. Gilmore is also affiliated with Novant Health Forsyth Medical Center. The medical group on file is Carolinas Pain Institute. Dmand AI also links Dr. Gilmore to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gilmore practices, 5 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Gilmore's primary specialty in the NPI Registry, under taxonomy code 208VP0000X. The record also lists pain medicine. Dr. Gilmore is licensed in North Carolina.

CMS data shows 2,756 Medicare services from Dr. Gilmore across 22 procedure codes in 2024, for 514 Medicare patients. Medicare paid $181,871 for them.

CMS counts 514 Medicare patients who saw Dr. Gilmore in 2024. The largest group is 65 to 74, with 235 patients. 75% of them have arthritis, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gilmore's median patient age at 66, with 65% women.

In 2024, Dr. Gilmore wrote 1,502 Medicare Part D claims for 455 patients. 91% of them were for generic drugs. CMS names the drug for 1,376 of them, across 26 drugs with 11 or more claims each, at $95,806 in total drug cost. In 2023, CMS named 1,181 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gilmore for performance year 2024, reported individually. Dr. Gilmore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gilmore as offering telehealth.

Dmand AI links 37 papers to Dr. Gilmore, published from 2012 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Pain Measurement, Chronic Pain and Low Back Pain. Dr. Gilmore has published most often in Neuromodulation. Dr. Gilmore's most frequent co-authors are Leonardo Kapural, MD, Timothy Ray Deer, MD and Jason Edward Pope, MD.

Dmand AI links Dr. Gilmore to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Complex Regional Pain Syndromes, Low Back Pain and Autonomic Nervous System Diseases. Mainstay Medical sponsors the most, 2.

CMS Open Payments shows 1,452 general payments to Dr. Gilmore from 48 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. SPR Therapeutics, Inc paid the most, $277,715. It also lists 4 research payments totaling $89 from 2019 to 2021.

Dr. Gilmore graduated from University of Tennessee, Hsc, College of Medicine in 2002.